Transparency-Rx

Where do we go from here? Transparency Is Rising panel discusses the next steps for #PBMReform. Continued action is needed from federal and state lawmakers. Legislation must target the misaligned incentives of traditional PBMs and crack down on anticompetitive practices.

At Transparency Is Rising, Sharon Faust with Navitus gave a presentation on drug pricing trends and what they mean for affordability. #healthcare

Traditional pharmacy benefit programs have become increasingly complex and opaque. But transparent #PBMs want to simply the process and bring clarity to employers. Below is a clip from our investor panel at Transparency is Rising:

Transparency is a Main Street Value: National forum discussion with @RxPreferred 🔹Pharmacy benefits can be simple and efficient 🔹PBM Conflicts of Interest = Inefficiency 🔹Data is king 🔹Transparency is a catalyst for change

New analysis found prescription drug denials by private insurers in the U.S. jumped by 25% from 2016 to 2023. The NYT report says not all decisions to deny claims are made directly by health insurance claims. Much of that work is done by #PBMs. nytimes.com/2025/07/18/hea…

As Senator @RonWyden described during his panel at Transparency Is Rising, our community-based & innovation-orientated #PBM partners are disrupting America's broken healthcare system, restoring financial responsibility & giving employers & patients more value for their dollar.

ICYMI: Transparency Is Rising: A Forum for Market Innovators Industry leaders, key stakeholders, and policy decision-makers gathered in D.C. last month to discuss how we can transform the healthcare system through transparency.

Former U.S. Surgeon General @JeromeAdamsMD joined our national forum for a panel on #transparency in action and the role in plays in a functioning #healthcare market.

"It takes radical transparency to make the benefits of capitalism come to healthcare." At Transparency Is Rising, @SenBillCassidy shared his insights on how radical transparency can transform the healthcare system, empowering families & employers to make informed decisions.

"Patients and employers alike deserve to know the price." Cynthia Fisher joined Mark Cuban during a panel at Transparency Is Rising to explain why opaque pricing models for consumers & businesses creates a dysfunctional market. @PtRightsAdvoc

Another inside look at Transparency Is Rising. CMS Administrator @DrOz shared how the federal agency is working to transform drug pricing, and pass down transparent data to patients & clinicians.

#CMS may have plans to release a rule by the end of this year requiring disclosure of prescription drug prices from healthcare companies, potentially including #PBMs. Dr. Oz hinted at this during our Transparency Is Rising event last month. insidehealthpolicy.com/inside-drug-pr….

"Trust is the ultimate product a company offers." At Transparency Is Rising, @mcuban shared how healthcare companies can create trust with clients & gave his insights into the challenges employers face within the pharmaceutical supply chain.

At our first national forum last month, CMS Administrator @DrOz said they hope to have a rule by the end of the year to enforce #transparency in the pharmaceutical supply chain. #PBMReform

The Senate Finance Committee's reconciliation package includes #PBMReform. ▪️Bans the use of spread pricing by PBMs in Medicaid ▪️Implements a 100% pass-through pricing structure ▪️Requires transparency & reporting insidehealthpolicy.com/inside-drug-pr…

Check out our full lineup of keynote speakers for the Transparency Is Rising event coming up in less than a week! @DrOzCMS @BillCassidy @mcuban @JeromeAdamsMD @RonWyden There is still time to register. Just click on the link below: eventcreate.com/e/transparency…

Mintz just released its PBM Policy and Legislative Update for Spring 2025. This breaks down recent federal & state legislative developments including important #transparency reforms & industry responses. mintz.com/insights-cente…

ICYMI: A 2024 survey by NAM found that 72% of manufacturers believe Congress should reduce costs by passing comprehensive #PBMReform. Traditional PBMs drive up healthcare costs for manufacturers and their workers. nam.org/issues/health-…

If passed, the reconciliation bill would establish #PBM transparency & reporting requirements. #Transparent PBMs already ensure companies are never in the dark about their pharmacy benefits. It's time traditional PBMs are held to the same standard. healthcareuncovered.substack.com/p/health-affai…

#PBMReform is in the latest reconciliation package. If passed, ASCO says the change "would represent a significant step toward increased transparency, help shift PBM incentives, and potentially lower patients’ out-of-pocket costs." asco.org/news-initiativ…